World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
117
Citations
78189
World Ranking
4120
National Ranking
158

Maarten Boers publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Maarten Boers sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 777 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Maarten Boers D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Maarten Boers sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 117 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Maarten Boers is affiliated with Vrije Universiteit Amsterdam in the Netherlands and focuses on medical research, primarily within the field of rheumatology. Over the course of their career, they have contributed extensively to research on rheumatoid arthritis and other autoimmune conditions.

Their recent notable publications include:

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update, 2020, Annals of the Rheumatic Diseases
  • COSMIN Risk of Bias tool to assess the quality of studies on reliability or measurement error of outcome measurement instruments: a Delphi study, 2020, BMC Medical Research Methodology
  • Recruitment and Retention of Older People in Clinical Research: A Systematic Literature Review, 2020, Journal of the American Geriatrics Society
  • Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies, 2021, The Lancet Rheumatology
  • Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial, 2022, Annals of the Rheumatic Diseases

Frequent collaborators in their research include:

  • Michael T. Nurmohamed
  • Willem F. Lems
  • Robin Christensen
  • Frank Buttgereit
  • Alexandre E. Voskuyl

The scholar has published extensively in venues such as:

  • Annals of the Rheumatic Diseases
  • Seminars in Arthritis and Rheumatism
  • Lara D. Veeken
  • RMD Open
  • The Lancet Rheumatology

Boers' research fields and subfields cover a broad spectrum within medicine, with a concentration on rheumatology. Other areas of study include immunology, economics and econometrics, surgery, and hematology.

The primary research topics addressed by Boers span:

  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Biosimilars and Bioanalytical Methods
  • Spondyloarthritis Studies and Treatments
  • Autoimmune and Inflammatory Disorders Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Osteoarthritis Treatment and Mechanisms

Best Publications

  • Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews

    Beverley J Shea;Jeremy M Grimshaw;George A Wells;Maarten Boers

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch

  • American college of rheumatology preliminary definition of improvement in rheumatoid arthritis

    David T. Felson;David T. Felson;Jennifer J. Anderson;Jennifer J. Anderson;Maarten Boers;Claire Bombardier;Claire Bombardier

  • The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus.

    Arianne P. Verhagen;Henrica C.W. de Vet;Robert A. de Bie;Alphons G.H. Kessels

  • The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.

    Felson Dt;Anderson Jj;Boers M;Bombardier C

  • AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews.

    Beverley J. Shea;Candyce Hamel;George A. Wells;Lex M. Bouter

  • American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

    David T. Felson;David T. Felson;Josef S. Smolen;George Wells;Bi Zhang

  • Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

    Maarten Boers;Arco C Verhoeven;Harry M Markusse;Mart Afj van de Laar

  • Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.

    Harm Van Tinteren;Otto S. Hoekstra;Egbert F. Smit;Jan H.A.M. Van Den Bergh

  • Recommendations for a core set of outcome measures for future Phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III

    Nicholas Bellamy;John Kirwan;Maarten Boers;Peter Brooks

  • The OMERACT filter for Outcome Measures in Rheumatology.

    M Boers;P Brooks;C V Strand;P Tugwell

  • How to select outcome measurement instruments for outcomes included in a “Core Outcome Set” – a practical guideline

    Cecilia A. C. Prinsen;Sunita Vohra;Michael R. Rose;Maarten Boers

  • COBRA Combination therapy in patients with early rheumatoid arthritis: Long-term structural benefits of a brief intervention

    Robert B. M. Landewé;Maarten Boers;Arco C. Verhoeven;Rene Westhovens

  • Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0

    Maarten Boers;John R. Kirwan;George Wells;Dorcas Beaton

  • OMERACT: An international initiative to improve outcome measurement in rheumatology

    Peter Tugwell;Maarten Boers;Peter Brooks;Lee Simon

  • Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.

    D. Aletaha;R.B. Landewe;T. Karonitsch;J. Bathon

  • External Validation of a Measurement Tool to Assess Systematic Reviews (AMSTAR)

    Beverley J. Shea;Lex M. Bouter;Joan Peterson;Maarten Boers

  • Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology

    F. Buttgereit;J.A. da Silva;M. Boers;G.R. Burmester

  • Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data

    J A P Da Silva;J W G Jacobs;J R Kirwan;M Boers

  • Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRÉ Investigation

    V P van Halm;M J L Peters;A E Voskuyl;M Boers

Frequent Co-Authors

Peter Tugwell
Peter Tugwell University of Ottawa
Willem F. Lems
Willem F. Lems Vrije Universiteit Amsterdam
Robert Landewé
Robert Landewé University of Amsterdam
John R. Kirwan
John R. Kirwan University of Bristol
George A. Wells
George A. Wells University of Ottawa
Vibeke Strand
Vibeke Strand Stanford University
Caroline B. Terwee
Caroline B. Terwee VU University Medical Center
Peter Brooks
Peter Brooks University of Melbourne
Robin Christensen
Robin Christensen University of Southern Denmark
Désirée van der Heijde
Désirée van der Heijde Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical careers in the USA doesn't always require a traditional path. There are numerous academic options for students and professionals seeking flexibility, faster completion, or a specific specialty in their studies.

For nurses aiming for the highest level of practice, the shortest dnp programs offer advanced clinical skills with a more accelerated timeline. If workload or intensity is a concern, the easiest online dnp programs may provide a better balance, making it possible to upskill without overwhelming demands.

Entry-level nursing roles can also be reached quickly with accelerated lpn programs. These allow learners to start working in healthcare much sooner than with traditional programs. For those interested in mental health, the online pmhnp programs support a rapid transition into this high-demand specialty.

With these diverse online programs, individuals can pursue rewarding healthcare careers more efficiently and in ways that suit unique circumstances and career goals.

Best Scientists Citing Maarten Boers

Trending Scientists

Recently Published Articles